aod9604 igf1 levels study Frontiers PDF] Safety and Metabolism of

AOD-9604 is a downstream fragment of growth hormone, not GHRH

Description Overview 5-Amino-1MQ is a selective NNMT inhibitor that elevates cellular NAD+ and SAM to enhance mitochondrial function, fat oxidation, insulin sensitivity, and overall metabolic efficiency, with preclinical data indicating preferential visceral fat loss and a favorable safety profile

The glucagon-receptor arm is what distinguishes Retatrutide from Semaglutide and Tirzepatide

Though not yet proven, limited evidence suggests an increased cancer risk in those with higher-than-normal B12 levels

This reduces blood sugar levels and decreases the amount of glucose available for conversion to fat